ELI LILLY & Co — Director's Dealing 2025

Nov 14, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-11-07

Reporting Person: Brown Adrienne S (EVP, President LLY Imm)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3725	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2026-02-16	Common Stock (391)		Direct
Restricted Stock Unit	$	2026-11-01	Common Stock (2530)		Direct
Restricted Stock Unit	$	2027-02-16	Common Stock (394)		Direct
Restricted Stock Unit	$	2028-02-16	Common Stock (354.091)		Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.